ZACHARY LADNER: Open Payments
NPI 1699986935 · BRENTWOOD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,232 in 57 payments from 15 companies in 2025. Trend: 2023 $1,341 · 2024 $1,505 · 2025 $1,232
Food & beverage: $1,232
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 14 | $279 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $200 |
| Merck Sharp & Dohme LLC | 7 | $142 |
| Amgen Inc. | 6 | $97 |
| AstraZeneca Pharmaceuticals LP | 5 | $86 |
| E.R. Squibb & Sons, L.L.C. | 3 | $77 |
| Lilly USA, LLC | 4 | $63 |
| AtriCure, Inc. | 3 | $58 |
| Esperion Therapeutics, Inc. | 2 | $49 |
| Edwards Lifesciences Corporation | 2 | $41 |
Products named: LEQVIO, LifeVest, REPATHA, VERQUVO, CAMZYOS, FARXIGA, MOUNJARO, ATRICLIP LAA EXCLUSION SYSTEM.
Industry payments across CA — which companies pay providers there.
